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Shortly after the limb is
amputated, the epithelium
layer covers the exposed
limb bud, forming the wound
epithelium (WE). 
A group of stem cells
collects below this layer, 
forming the blastema. 
The WE signals the stem 
cells below it to rebuild the 
limb, recreating the limb
from the point of injury out 
towards the hand. 
The final regenerated limb is
indistinguishable from the 
original.
LESS STEM CELLS NEEDED THAN
FORESEEN

WHAT DOSE DO WE NEED…….ARE WE USING TOO
HIGH DOSES?
FISH AND MOUSE
THERAPEUTIC USE OF 
ENVIRONMENTAL
CHANGES
• Apart from some 
« sanatoria » and other 
plane fligths to cure 
pertussis.
• The real therapeutic use 
of environmental changes 














EMPIRICAL USE, ADAPTATION 
OF WHAT WAS ALREADY USED
FOR DIVERS
Is empirism wrong?






• The same sample being
mesured before and 
after the time needed
for the intervention but 
without it
• Time machine needed !!
PLACEBO
The term “placebo” comes from the 
St. Jerome’s Latin translation of the 
Bible in Psalm 114:9 Placebo Domino 
in regione vivorum: “I will please”. This 
reference was used in the offices for 
the dead and is related to liturgy that 
funnels by definition a number of 
feelings, sensibility, understanding 
and analysis. 
Fig 1. Rationale of the study.
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Fig 2. Experimental 
design.
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Fig 3. No-treatment group.
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Fig 4. Means (+SD) for all the measurements in the oxygen group.
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Fig 5. Means (+SD) for all the measurements in the aspirin group.
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Fig 6. Means (+SD) for all the measurements in the mixed group.
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Fig 8. Model that explains the 
findings of the present study.
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Eric Kandel – Aplysia Californica
IN A NUTSHELL
•Ritual is the clue, mixing placebos doesn’t
work (goes back to the origin of placebo)
•Physiotherapy sessions or Hyperbaric Oxygen
sessions are a «ritual» by essence.
• It appears that totally exclude placebo effect
is not feasible.
MISTAKE…….
IF VASCULARISATION IS STILL PRESENT AND 
EFFECTIVE










MANUAL LYMPHATIC DRAINAGE 
(LEDUC)
UPPER LIMD EDEMA 
TREATEMENT
























































































Maximum O2 Diffusion Distance From a Functional 
Capillary
120 - 140 µm






























































































































• Erythropoietin (EPO) regulates RBC homeostasis but also known as 
antiapoptotic neuroprotective agent
• Polypeptid (cytokine) hormone (Bazan, 1990)
Production in renal proximal tubular cell, in 
response to tissue hypoxia (Goldwasser, 1957)
Normal plasma values : 5 - 25 mU/ml
Circadian rhythm: litterature discordances
(Wide 1989, Cahan 1992, Miller 1981, Cotes & Brozovic
1982, Klausen 1993)
POSSIBLE OTHER STIMULUS ?
•Serum EPO measurements in apnea divers after 3 dives to -
40 m (1999 Malta EUBS Meeting)
• [EPO] markedly elevated !
•Hypothesis: tissular pO2 variation as a stimulus for EPO 
production
Descent











CONCEPT OF "RELATIVE 
HYPOXIA"
Tissue N2-O2 balance : increase in relative N2 content






-20°C freezing of plasma
RIA assay < 24hrs
HYPERBARIC HYPEROXIA
Belgian ARMY Hyperbaric Chamber
Percentual variation of EPO
plasmatic concentration






























































Plasma [EPO] after 120 min. of normobaric
100% oxygen breathing




























[EPO] Plasma variation after HOB










y = -1.59 + 80.54
R²=0.61 p=0.038

















































GSH neutralises some, 
not all OH and converts 
to GSSG
Extreme situation ! In less 
severe hypoxia, GSH 







































Extra GSH neutralises all OH 

























































GSH out of 
GSSG; in mean 
time: spill of OH 
to permit Ub
Excessive production of 









































Extra GSH neutralises all OH 







THE ABYSS PROJECT (PONZA ITALY)
Serum EPO levels after several days
at 9 m depth in water habitat
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CLINICAL APPLICATION : 
METHODS
Two radomized groups of patients target number n=24
Post cardiac surgery
No hypoxia allowed
No Haemoglobin levels drop 
EPO Level in Cardiac Patients
post O2 administration
(randomely assigned groups)































































Levels of Hb (g/dl) in two 
patients breathing 
oxygen. The first 100% 
O2 every other day with 
adjuvant drug therapy 
(Darbepoetin Alpha + IV 
iron) (Myelofibrosis), The 
second breathing 40% 
O2 3 times per week with 





Hb Variation after 100% O2 breathing



























































Hb Variation after O2 breathing





















































Hb variation after different PO2 breathing
(30 min every other day)
(100% and15%)
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INTERMITTENT OXYGEN
HYPOXIA-HYPEROXIA
Hb Variation after O2 breathing





















































Hb variation after different PO2 breathing
(30 min every other day)
(100% and15%)


























• Traumatic orthopaedic patients (n=80)
• Followed after surgery for 7 days
• Mean age +/- 80
• Randomized in two groups
• 1 h/day Oxygen
• 1 h/day Air
• Blinded, no therapeutic change

TRANSFUSION RATE
Transfusion No transfusion Total
Oxygen 3 37 40
Air 14 26 40
Total 17 63 80
p = 0.019, two tailed Fischer’s exact test
•1,2 ± 0,7 RBC/patient Air 




































Congratulations From the 







NAC - I - O2
« Pluralitas non 
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Are You Drunk ?
YES NO

THINGS CAN ALWAYS GO WRONG
EVEN WHIT FORESEEN EVENTS….


